(CGEM) Cullinan Oncology - Performance -51.7% in 12m
CGEM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-73.90%
#111 in Peer-Group
Rel. Strength
8.57%
#7017 in Stock-Universe
Total Return 12m
-51.73%
#133 in Peer-Group
Total Return 5y
-73.89%
#88 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 6.30 |
| High / Low | USD |
|---|---|
| 52 Week High | 20.86 USD |
| 52 Week Low | 7.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 50.74 |
| Buy/Sell Signal +-5 | 0.97 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CGEM (-51.7%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CGEM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CGEM
| Total Return (including Dividends) | CGEM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -13.89% | 3.36% | 5.25% |
| 3 Months | 5.40% | 15.73% | 24.13% |
| 12 Months | -51.73% | -7.02% | 14.15% |
| 5 Years | -73.89% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | CGEM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -85% | 4.4% | 81% |
| 3 Months | 27.6% | 78.8% | 96.9% |
| 12 Months | -93.5% | -85.8% | 44.9% |
| 5 Years | -55.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th18.00 | -16.69% | -18.18% |
| 3 Month | %th35.50 | -8.93% | -15.09% |
| 12 Month | %th34.00 | -48.08% | -57.72% |
| 5 Years | %th62.50 | -54.28% | -85.05% |
FAQs
Does Cullinan Oncology (CGEM) outperform the market?
No,
over the last 12 months CGEM made -51.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months CGEM made 5.40%, while XBI made 15.73%.
Performance Comparison CGEM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CGEM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.1% | -19.1% | -39.4% | -66% |
| US NASDAQ 100 | QQQ | -0.8% | -19.2% | -40% | -64% |
| German DAX 40 | DAX | 1.1% | -12.5% | -51.5% | -81% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.9% | -17.1% | -42.8% | -72% |
| Hongkong Hang Seng | HSI | -0.7% | -20% | -58.8% | -90% |
| India NIFTY 50 | INDA | 0.8% | -17.4% | -39.7% | -51% |
| Brasil Bovespa | EWZ | -3.5% | -22.7% | -64.4% | -62% |
CGEM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.3% | -19.8% | -43.5% | -76% |
| Consumer Discretionary | XLY | -0.6% | -17.1% | -31.7% | -70% |
| Consumer Staples | XLP | -1.4% | -14.5% | -41% | -61% |
| Energy | XLE | -1.4% | -21% | -35.3% | -52% |
| Financial | XLF | -1.8% | -19% | -44.3% | -82% |
| Health Care | XLV | -0.5% | -16% | -32% | -47% |
| Industrial | XLI | -1.2% | -18.1% | -47.2% | -77% |
| Materials | XLB | -3.3% | -18.2% | -43.9% | -58% |
| Real Estate | XLRE | -1% | -14.9% | -39.1% | -65% |
| Technology | XLK | -1.8% | -22.6% | -41.7% | -63% |
| Utilities | XLU | 0% | -15.7% | -42.6% | -75% |
| Aerospace & Defense | XAR | 1.1% | -21% | -57.9% | -101% |
| Biotech | XBI | -2.1% | -17.3% | -26.2% | -45% |
| Homebuilder | XHB | -3.6% | -20.9% | -32.2% | -57% |
| Retail | XRT | -3.6% | -18.9% | -35.1% | -63% |
CGEM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2% | -22.3% | -31.0% | -44% |
| Natural Gas | UNG | 8.4% | -4.1% | -22.6% | -49% |
| Gold | GLD | -1.3% | -12.7% | -60% | -91% |
| Silver | SLV | -2.1% | -20.8% | -56.7% | -69% |
| Copper | CPER | -0.1% | -18.5% | -56.4% | -63% |
CGEM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.8% | -14.9% | -35.9% | -50% |
| iShares High Yield Corp. Bond | HYG | 0.1% | -15.5% | -38.3% | -62% |